Chikungunya

Mosquito-borne viral infections continue to pose recurring public health challenges, particularly in tropical and subtropical regions. Chikungunya is a viral disease transmitted primarily by Aedes mosquitoes, characterized by sudden onset of fever and severe joint pain that can persist for months. The disease has gained global attention due to its rapid spread and potential to cause large outbreaks. This session at the Infectious Diseases Conference focuses on epidemiology, clinical features, and effective control strategies for chikungunya.

Transmission occurs when infected mosquitoes bite humans, with urban environments providing ideal conditions for vector breeding. The disease often presents with high fever, joint pain, muscle aches, and rash. While mortality is relatively low, the prolonged joint symptoms can significantly impact quality of life. Early diagnosis is important for patient management and for distinguishing chikungunya from other similar infections such as dengue and Zika virus infections.

Effective control of chikungunya relies heavily on vector management and public health interventions. Eliminating mosquito breeding sites, promoting community awareness, and implementing surveillance programs are essential steps in reducing transmission. Advances in diagnostic methods, including molecular testing, have improved detection accuracy, while ongoing research is focused on vaccine development and innovative prevention strategies.

In medical literature and public health discussions, Chikungunya Virus Infection is used interchangeably to describe the same condition, emphasizing its viral origin. By addressing both clinical and environmental aspects, this session provides valuable insights into reducing disease burden and strengthening preparedness against mosquito-borne outbreaks.